
Artrya
AYA.AXArtrya Limited Price (AYA.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
78,642,982
(0.334)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.2-1.04
- Market Cap 73.66M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Healthcare Information Services
- ceo: Mr. Mathew Regan
- IPO Date: November, 25, 2021
- Country: AU
- Currency: AUD
- Headquaters: West Perth, WA
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
